Share on LinkedInShare on LinkedIn

ARTICLE · 07 FEBRUARY 2023

Another One Bites The Dust: DOJ Pulls 3 Policy Statements, Leaving Trade Associations Guessing

During the course of the Biden Administration, the U.S. Department of Justice (DOJ) and Federal Trade Commission (FTC) have demonstrated an invigorated and sustained policy interest...

United StatesAntitrust/Competition Law

Highlights

  • The Antitrust Division of the U.S. Department of Justice (DOJ) on Feb. 2, 2023, announced its withdrawal of antitrust policy statements applicable to healthcare markets, expressing a preference for a "case-by-case" enforcement approach over advance guidance for industry participants.
  • Withdrawal of the policy statements creates uncertainty for entities outside of the healthcare industry that had relied on an established antitrust "safety zone" when conducting industry benchmarking surveys.
  • Going forward, trade associations and others conducting surveys or supervising information exchanges among industry participants cannot depend on rigid adherence to the safety zone factors to avoid antitrust scrutiny. Before proceeding, trade associations will instead need to consider how, if at all, the proposed survey could reduce competition.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from